VC Fund Investments
Vaccine technology startup Mynvax raises $2-M from Inviga Healthcare Fund
Mynvax , a Bangalore-based biotech startup focused on developing novel recombinant vaccines for human respiratory viral diseases, including seasonal influenza and Covid-19, has raised USD 2 million from Inviga Healthcare Fund.
In Jul-21, Mynvax - which was incubated at IISc-Bangalore - had raised USD 4.2 million in a round led by Accel India with participation from Kotak PE, Lets Venture and other angel investors.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
